ブックタイトルHealth Management for Female Athletes
- ページ
- 83/90
このページは Health Management for Female Athletes の電子ブックに掲載されている83ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「ブックを開く」ボタンをクリックすると今すぐブックを開きます。
このページは Health Management for Female Athletes の電子ブックに掲載されている83ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「ブックを開く」ボタンをクリックすると今すぐブックを開きます。
Health Management for Female Athletes
26. Zderic TW et al. Glucose kinetics and substrate oxidation during exercise in the follicular andluteal phases. J Appl Physiol, 90(2), 447-453, 2001.27. Peters C and Burrows M. Androgenicity of the progestin in oral contraceptives does not affectmaximal leg strength. Contraception, 74(6), 487-491, 2006.28. Ekenros L et al. Oral contraceptives do not affect muscle strength and hop performance in activewomen. Clin J Sport Med, 23(3), 202-207, 2003.29. Giacomoni M et al. Influence of the menstrual cycle phase and menstrual symptoms on maximalanaerobic performance. Med Sci Sports Exerc, 32(2), 486-492, 2000.30. Rechichi C and Dawson B. Effect of oral contraceptive cycle phase on performance in team sportplayers. J Sci Med Sport, 12(1), 190-195, 2009.31. Bushman B et al. Anaerobic power performance and the menstrual cycle: eumenorrheic and oralcontraceptive users. J Sports Med Phys Fitness, 46(1),132-137, 2006.32. Renstrom P et al. Non-contact ACL injuries in female athletes: an International OlympicCommittee current concepts statement. Br J Sports Med, 42(6), 394-412, 2008.33. Heitz NA et al. Hormonal changes throughout the menstrual cycle and increased anteriorcruciate ligament laxity in females. J Athl Train, 34(2), 144-149, 1999.34. Park SK et al. Alterations in knee joint laxity during the menstrual cycle in healthy women leadsto increases in joint loads during selected athletic movements. Am J Sports Med, 37(6), 1169-1177,2009.35. Dragoo JL et al. Relaxin receptors in the human female anterior cruciate ligament. Am J SportsMed, 31(4), 577-584;,2003.36. Dragoo JL et al. Prospective correlation between serum relaxin concentration and anteriorcruciate ligament tears among elite collegiate female athletes. Am J Sports Med, 39(10), 2175-2180, 2011.37. Dragoo JL et al. Trends in serum relaxin concentration among elite collegiate female athletes. IntJ Womens Health, 19(3), 19-24, 2011.38. Rechichi C et al. Athletic performance and the oral contraceptive. Int J Sports Physiol Perform,4(2), 51-62, 2009.39.能瀬さやから,婦人科疾患治療におけるドーピング禁止物質,臨床スポーツ医学, 33(2) , 192-197, 2016.40.世界ドーピング防止規程2016年禁止表国際基準:日本アンチ・ドーピング機構2016.81